The ‘Doc’ is in: Assistance dog provides comfort to patients with cancer ‘He’s a good boy. And he brings people joy’: Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
OHSU uses bioelectric medicine in vagus nerve to help patients heal from stroke, arthritis October 01, 2026
OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol September 29, 2026
Tech that detects cause of preemie blindness gets federal nod By Franny White January 30, 2020 Artificial intelligence algorithm receives FDA breakthrough device status.
OHSU, Ionis Pharmaceuticals to develop drugs for ‘undruggable’ cancer targets By Amanda Gibbs January 27, 2020 Collaboration aims to expedite discoveries for patients with leukemia.
Oncologist focused on HPV in Native American women named national fellow By Franny White January 24, 2020 Amanda Bruegl honored by Robert Wood Johnson Foundation’s Harold Amos Medical Faculty Development Program.
Three OHSU scientists earn $2.25 million to accelerate innovation, collaboration January 23, 2020 Inaugural Faculty Excellence Awards will fund research in marijuana use in pregnancy, new therapies for heart disease, leukemia.
Drug for rare gastrointestinal cancer approved by FDA By Amanda Gibbs January 21, 2020 OHSU patient began treatment with a tumor more than 15 inches in length.
Generic MS drug barely constrains price hikes, study finds By Erik Robinson January 16, 2020 OHSU, OSU researchers examine commonly prescribed medication for multiple sclerosis.
Hikikomori: New definition helps identify, treat extreme social isolation By Erik Robinson January 10, 2020 Modern tools to improve interpersonal communication may be having the opposite effect.
Study aims to improve traumatic brain injury outcomes By Erik Robinson January 06, 2020 OHSU will help compare two treatment protocols to determine the preferred standard.
A dozen opportunities to reduce inequity in cancer care By Amanda Gibbs December 20, 2019 OHSU researchers lend expertise to six distinct publications on improved cancer prevention activities.
FDA recommends approval of eye drug tested in Portland By Franny White December 16, 2019 OHSU is part of multi-center study testing teprotumumab for thyroid eye disease.